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The stem bark of Galipea longijlora is used by the Chimane Indians in Bolivia for the treatment of cutaneous 
leishmaniasis produced by Leishmania brazi2iensis. Petroleum ether and chloroform extracts of stem, root bark 
and leaves were found active in vitro against Leishmania ssp and Trypanosoma cruzi at 100 &mL. The activity 
guided fractionation of the extracts by chromatography afforded 12 active compounds identified as 2-substituted 
quinoline alkaloids. BALBh mice were infected with Leishmania amazonensis (strain PH8 or H-142) and treated 
24 h after infection with the major alkaloids from the crude alkaloidal extract; 2-phenylquinoline and 2-n- 
pentylquinoline. 2-phenylquinoline was as potent as Glucantime (Rhône-Poulenc) against the strain H-142, but 
less active than the reference drug against the virulent strain PH8 of L. amazonensis. 2-n-pentylquinoline did not 
exhibit any activity. Assays of single local treatments on the rear footpad infection, 2 weeks after the parasitic 
inoculation, indicated an effect for 2-phenylquinoline by reducing the severity of lesion. However, this activity 
was found to be slightly lower than that obtained using Glucantime. 
Keywords: alkaloids; quinoline; Galipea lortgiflora; Rutaceae; Leishmania ssp., Trypanosoma cruzi. 
INTRODUCTION 
Cutaneous and mucosal leishmaniasis, caused by the 
protozoan Leishmania braziliensis, are common infec- 
tions in the subtropical areas of the Department of La 
Paz (Yungas and Alto-Beni) and the foothills of the 
Andes (Department of Beni) where the Chimane 
Indians live. Cutaneous leishmaniasis is known as 
espundia by the natives of this region of Bolivia called 
Oriente. The infection is classically treated with penta- 
valent antimony (Glucantime, Rhône-Poulenc) for 
cutaneous leishmaniasis or with amphotericin B for 
mucosal leishmaniasis. These drugs are administered 
parenterally to patients in hospitals which are often far 
from their colonies. These treatments are also too 
expensive or unavailable for the population suffering 
from espundia. The dispersion of cutaneous leishma- 
niasis is accentuated in subandean tropical regions by 
the influx of people descending from higher areas. The 
use of medicinal plants is commonplace, especially 
among the Chimane Indians, a group that inhabits the 
gallery forest and sandbars of the Rio Maniqui and its 
tributory streams. We have collected and studied many 
medicinal plants (Fournet, 1991) and most notably a 
tree called euanta, used by the Chimane Indians for the 
treatment of cutaneous leishmaniasis and botanically 
identified as Galipea longiflora Krause (Rutaceae). The 
stem bark, in the form of a poultice, is applied on the 
cutaneous leishmaniasis until complete cicatrization of 
the wound. In a preliminary screening, the crude alka- 
loidal extracts of the stem bark, root bark and leaves of 
Galipea longiflora displayed activity in vitro at a con- 
centration of 100 pg/mL against three strains of pro- 
mastigote forms of Leishmania species, L. braziliensis, 
L. amazonensis and L. donouani, and three strains of 
epimastigote forms of Trypanosoma cruzi (Tulahuen, 
C8CL1 and Tehuentepec), another trypanosomatid 
responsible for Chagas' disease. Activity-directed frac- 
tionation and purification of crude alkaloidal extracts in 
petroleum ether and in chloroform of root bark, stem 
bark and leaves gave 12 active compounds, identified 
by their physical and spectral data as 2-aryl and 2-alkyl 
quinolines alkaloids (Fournet et al., 1989, 1991). 
This work describes the in vitro antileishmanial and 
trypanocidal activities of the 12 quinolines alkaloids 
and the in uivo activitv of two maior alkaloids of 
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pentylquinoline in BALB/c mice infected with 
Leishmania amazonensis (IFLA/BR/67/PH8) or 
MHOM/GF/84/CAY-H-142). We sought to verify the 
effect of the most abundant alkaloid of Galipea longif- 
lora, 2-phenylquinoline, when administered directly in 
the rear footpad of infected BALBlc mice by 
Leishmania amazonensis. 
MATERIALS AND METHODS 
Isolation and chemistry 
General experimental procedures. UV spectra were 
recorded on a Unicam SP 1800 spectrophotometer. IR 
spectra were measured in KBr with a Perkin Elmer 257 
spectrometer. All 'H and 13C-NMR spectra were 
recorded in CDCl, (6ppm) on a Bruker AC200P 
spectrometer operating at 200 and 50 MHz respecti- 
vely. Eims spectra were obtained at 70 eV on a Nermag 
R 1010 C mass spectrometer. 
Plant material. Stem bark (3.5 kg), root bark (350 g) and 
leaves (3.5 kg) of Galipea longiflora Krause were 
collected by A. Fournet (A.F. 850) in August 1989, at 
Fatima de Chimane, in the Department of Beni, alti- 
tude 400 m, Bolivia. The plant material was identified 
by Dr J. A. Kallunki of the New York Botanical 
Garden. A reference specimen is deposited in the 
National Herbarium of Bolivia (La Paz). 
Extraction and isolation. The isolation procedure was 
effected by activity-directed fractionation and purifica- 
tion of the crude alkaloidal extracts of root bark, stem 
bark and leaves. Extraction, partitioning, chromato- 
graphic separation and physicochemical data of the 12 
alkaloids identified were performed as described by 
Fournet et al. (1989) and Fournet (1991). 
Biological assays 
Parasites. Cultures of Leishmania ssp and Trypanosoma 
cruzi were obtained from IBBA (Instituto Boliviano de 
Biologia de Altura, La Paz) and identified by iso- 
enzyme analysis. 
Five strains of Leishmania were used during these 
investigations, L.  braziliensis (MHOWBRI75lM 2903), 
L. amazoizeiisis (IFLA/BR/67/PH8), L. arnazonensis 
(MHOM/GF/84/CAY H-142), L. doriovani (MHOW 
IN/83/HS-70) and L. donouani (MHOWBN74IM 
2682), and five strains of Trypanosoma cruzi: 
SC 43 CL2 (Bolivian strain), C8 CL1 (Brazilian strain), 
Tulahuen (isolated from Triatoma infestans in Brazil), 
TeCL2 (Brazilian strain) and 1979 CL1 (Bolivian 
strain). 
Promastigote forms of Leishmania were grown at 
28 "C in USMARU medium (Evans, 1987) containing 
10% heat inactivated (56°C for 30mn) fetal bovine 
serum and epimastigote forms of T. cruzi in liver 
infusion tryptose medium (LIT, Bacto) supplemented 
with 10% fetal calf serum at 28 "C with an inoculum of 
lo6 cells per mL. Logarithmically growing promasti- 
gotes and epimastigotes were maintained by transfer- 
ring lo6 cells per mL. The extracts and the fractions of 
Galipea longiflora were dissolved in a known volume of 
DMSO (dimethyl sulphoxide) and then in medium, 
from which aliquots were drawn. Parasites were 
counted after 48 h of contact with drugs in a haemo- 
cytometer and the counts were compared with those 
of controls grown without drug. The 90% inhibitory 
concentrations (ICgo) were chosen for the comparison 
of susceptibilities of the strains to drugs tested. 
N-methylglucamine antimonate (Glucantime) 
(Rhône-Poulenc, France) and Pentamidine (May and 
Baker, England), nifurtimox (Bayer, Germany) and 
benznidazole (Roche, USA) were used as the baseline 
drugs against which the efficacy of the quinoline alka- 
loids of Galipea longiflora were compared. Each assay 
was performed in triplicate. 
In vivo studies 
The mouse footpad infection was used as a model for 
these experiments (Avila et al., 1990; Coleman et al., 
1989). 
Female and male BALB/c mice were supplied by the 
Charles River Breeding Laboratory and were then bred 
in IBBA (Bolivia). Mice weighed between 18-20 g and 
were 8 weeks old when bioassays were initiated. 
Leishrnaiiia amazonensis IFLNBRI67IPH8 and 
MHOM/GF/84/CAY-H-142 were used. BALB/c mice 
( I I  = 10 or ri = 8) were infected subcutaneously in the 
right rear footpad with 1 x lo6 amastigotes obtained 
from donor hamsters. The parasites were delivered in 
200 yL phosphate buffered saline (PBS). 
The growth of the lesion was determined weekly by 
measuring the diameter of both rear feet with a direct 
reading vernier caliper (Kroelin 10DI  00T6). The size 
of lesion in millimetres (Index of Leishmaniasis) was 
calculated by subtracting the measurements obtained 
from the uninfected foot from that of the infected foot. 
Measurements commenced 1 day prior to the inocula- 
tion of amastigotes and were continued' for 8 weeks. 
For each experiment, the mean and standard error of 
the mean (SEM) were calculated. 
N-methylglucamine antimonate (Glucantime) with a 
pentavalent antimony (Sb") content of 28% by weight 
was obtained from the Rhône-Poulenc, France and was 
used as a reference drug. 
Two experiments were conducted. Mice in the first 
experiment were treated by the subcutaneous route. 
Glucantime was given at a dose of 56 mg Sb' per kg per 
day and quinoline alkaloids (2-phenylquinoline and 
2-ti-pentylquinoline) at 100 mglkglday . The quinoline 
alkaloids were dissolved in 40 yL of polysorbate 
(Tween 80, Prolabo). Glucantime was dissolved in PBS 
and untreated mice received PBS and Tween 80. Drug 
treatment commenced 1 day after the inoculation of 
amastigotes and was continued once daily for 14 days. 
In the second experiment, mice were treated directly 
on the infected rear footpad with a single treatment 
14 days after the inoculation of parasites. For this 
experiment, the mice were treated with Glucantime at 
a rate of 112mg Sb' per kg per day and with the 
major quinoline alkaloid of Galipea longiflora, 
2-phenylquinoline at 200 mglkglday. 
, 
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2-phenylquinoline (I) Z-n-penW.ydnoline (II) 2-n-propylquinoline (III) 
4-methoxy-2-phenylquinoline (IV) 2-(3,4-methylenedioxyphenylethyl)quinoline (V) 
4-methmy-2-n-pentylquinoline (VI) Chimanine A (VII) 
OMe 
Cusparine (VIII) 2-(3,4dimethoxyphenylethyl) quinoline (IX) 
OMe 
Skimmianine (X) Chimanine B (XI) Chimanine D (XII) 
Figure 1. Structures of twelve 2-substituted quinolines isolated 
from Galipea longiflora by activity guided fractionation. 
RESULTS ANDDISCUSSION 
The crude alkaloidal extracts of stem bark, root bark 
and leaves of Galipea long@ora showed an activity on 
promastigote forms of Leishmania ssp. and epimasti- 
gote forms of Trypanosoma cruzi. The fractionation 
and purification, monitored by bioassays, led to isola- 
tion of 12 active quinoline alkaloids. The new products, 
the four chimanines (A, B, C and D) were described by 
Fournet in 1991. The chemical structures of these 
products are presented in Fig. 1. Chimanine C was not 
tested against parasites since it was not isolated follow- 
ing the bioassay purification procedure. 
The results of the in vitro activity of these com- 
pounds are shown in Table 1 against five strains of 
promastigote forms of Leishmania species. Three qui- 
noline alkaloids showed activity against all strains of 
both parasites at 50 pg/mL; 2-n-propylquinoline (III), 
chimanine B (XI) and chimanine D (XII). All these 
compounds are substituted in position 2 with a propylic 
chain. We did not notice any different activity against 
Leishmania ssp. and T. cruzi or the same type of 
parasites. All quinoline alkaloids are more potent than 
Glucantime, but 25-100 times less active than pentami- 
dine against the promastigote forms of Leishmania 
species. It was impossible to confirm in vitro activity 
against the intracellular forms of Leishmania either 
with mouse peritoneal macrophages (Neal and Croft, 
1984) or with cell lines U937 (Martinez et al., 1988). 
This failure seemed to be due to a lack of good 
technical conditions and effects of altitude (3500 m). 
___ 
Tablel. Comparison of in vitro inhibitory effects (ICw 
(pg/mL) on five strains of promastigote forms 
of Leishmania at 48 h after addition of twelve 
2-substituted quinolines, pentamidine and 
N-methylglucamine antimonate 
ICSO (pg/mLl 
L.6." L.a.b L.a.b L.d.C L.d.C 
Drug (2903) (PH 8)  (H-1421 (2682) (HS70) 
2-Phenylquinoline (I) 100 100 100 100 100 
2-n-Pentylquinoline (Il) 100 100 100 100 100 
2-n-Propylquinoline (111) 50 50 50 50 50 
4-Methoxy-2-phenylquinoline (IV) 50 50 50 50 50 
2-(3,4-Methylenedioxyphenylethyl) 100 100 100 100 100 
quinoline (V) 
4-Methoxy-2-n-pentylquinoline (VI) 100 100 100 100 100 
Chimanine A (VII) 100 100 100 100 100 
Cusparine (VIII) 100 100 100 100 100 
2-(3,4-Dimethoxyphenylethyl) 100 100 100 100 100 
quinoline (1x1 
Skimmianine (X) 100 100 100 100 100 
Chimanine B (XI) 25 25 25 25 25 
Chimanine D (XII) 25 25 25 25 25 
Pentamidine 1 1 1 1 1  
N-methylglucamine antimonate >IO0 >IO0 >IO0 >IO0 >IO0 
a Leishmania braziliensis, Leishmania amazonensis, 
Leishmania donovani 
The in vitro effects of the quinoline alkaloids, nifurti- 
mox and benznidazole against five strains of epimasti- 
gote of Trypanosoma cruzi are presented in Table 2. 
Nine quinoline alkaloids were less active than nifurti- 
mox and benznidazole, and three (Zn-propylquinoline 
(III), chimanine B (XI) and chimanine D (XII) showed 
a similar activity to the reference drugs. 
We chose to determine the in uivo activity of two 
major quinoline alkaloids of the crude alkaloidal 
extracts of Galipea longiflora, in BALB/c mice infected 
with the strain PHS or H-142 of Leishmania amazonen- 
sis but not with the endemic cutaneous strain, L. 
braziliensis. The in vivo model of infection with this 
strain was obtained by coinjection with saliva and 
parasites isolated from infected sand fly (Samuelson et 
al., 1991). The major quinoline, 2-phenylquinoline, 
~~ ~~ 
Table2. Comparison of in vitro inhibitory effects (ICw (pg/ 
mL) on five strains of epimastigote forms of 
Typanosoina cruzi at 48 h after addition of twelve 2- 
substituted quinolines, benznidazole and nifurtimox 
GO (pglmLt 
CBCLl TeCLZTulahuen 1979 CL1 SC43 
Drug CL1 
2-Phenylquinoline (I) 100 100 100 100 100 
2-n-Pentylquinoline (II) 100 100 100 100 100 
2-n-Propylquinoline (111) 50 50 50 50 50 
4-Methoxy-2-phenylquinoline (IV) 100 100 100 100 100 
2-(3,4-Methylenedioxyphenylethyl) 1 O0 1 O0 1 O0 100 1 O0 
quinoline (V) 
4-Methoxy-2-n-pentylquinoline (VI) 100 100 100 100 100 
Chimanine A (VII) 100 100 100 100 100 
Cusparine (VIII) 100 100 100 100 100 
2-(3,4-Dimethoxyphenylethyl) 100 100 100 100 100 
quinoline (IX) 
Skimmianine (X) 100 100 100 100 100 
Chimanine B (XI) 25 25 25 25 25 
Chimanine D (XII) 50 50 50 50 50 
Benznidazole 100 25 50 25 50 
N ifu rti mox 25 25 25 50 50 
c, 
ANTIPROTOZOAL ACTIVITY OF QUINOLINE ALKALOIDS 
composed 67% of the total crude alkaloidal extract of 
stem bark and 48% of root bark, while 2-n- 
pentylquinoline represents 17% of stem bark. The 
drugs were daily administered 24 h after parasitic infec- 
tion at 100mg/kg for 14 days. The lethal dose killing 
50% of mice (LD5,,) was evaluated to be upward of 
400 mg/kg via the intraperitoneal route for each alka- 
loid. No apparent signs of drug toxicity:. weight loss, 
hair loss or diarrhoea, were observed in any experiment 
but there was the appearance of a weak inflammatory 
effect at the site of inoculation. Table 3 shows 
the results obtained in the first experiment with 
2-phenylquinoline (I) , 2-n-pentylquinoline (II) and 
Glucantime against the development of lesions in 
BALBlc mice infected with Leishrnania amazonensis 
(PH8) treated with these drugs. After 4 weeks, lesions 
in mice which had received 2-n-pentylquinoline were 
greater than 0.4 mm with respect to control mice, 1.64 
and 1.25 mm respectively. Also mice treated with 2- 
phenylquinoline (I) had developed smaller lesions 
( -  0.98 mm) than control mice. After 8 weeks, mice 
treated with 2-phenylquinoline (I), 2-n-pentylquinoline 
(II) and Glucantime had an average lesion size of 5.06, 
5.69 and 4.02 mm respectively versus 6.60 mm in the 
untreated controls. 
In the second experiment, the BALBlc mice were 
infected with the strain H-142 of Leishmania amazo- 
nensis. The results obtained from this experiment are 
detailed in Table 4. This strain developed lesions 
smaller than lesions obtained with the strain PH8 after 
8 weeks. During the first week, the lesions increased 
more rapidly than in the first experiment in all three 
groups of mice. For the next 7 weeks, the lesions 
increased more slowly, 0.5 mm in average for each 14 
days. During 7 weeks the mice treated with 2- 
phenylquinoline and with reference drug showed the 
same development of lesions. Finally, after 8 weeks, 
mice treated with quinoline alkaloids and mice receiv- 
ing Glucantime, exhibited identical sizes of lesions, 
2.54 and 2.51 mm respectively. 
In the third experiment, the BALBlc mice were 
infected with Leishniania amazonensis (PHS) and 
treated locally with a single dose of 2-phenylquinoline 
or Glucantime near the site of infection. The results 
obtained are presented in Table 5. After 6 weeks, the 
lesion size of mice which received 2-phenylquinoline 
and the untreated mice did not differ significantly, 2.62 
and 2.87 mm respectively. In the last 2 weeks, lesions in 
control mice increased more rapidly than lesions in 
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Table 4. Effect of N-methylglucamine antimonate (56 mg of 
Sb' per kg per day), 2-phenylquinoline (I) (100 mg/ 
kg/day) on the development of L. amazonensis H-142 
in BALBlc mice ( S E M ) .  Treatments were given for 
14 days period commencing 1 day after inoculation 
of L. amazonensis 
Diameter of lesion' 
Weeks post-infection Control Glucantime 2-Phenylquinoline (I)  
1 1.07 (0.19) 0.91 (0.17) 0.76 (0.14) 
2 1.37 (0.14) 1.32 (0.10) 0.92 (0.15) 
4 2.02 (0.22) 1.74 (0.15) 1.54 (0.16) 
6 2.85 (0.21) 2.17 (0.24) 2.08 (0.36) 
8 3.49 (0.26) 2.51 (0.26) 2.54 (0.21) 
a Average measurement (in mm) for 10 mice and +SEM. 
mice treated with 2-phenylquinoline or with the refer- 
ence drug, 2.03, 1.00 and 1.31 mm. 
These results explain the antileishmanial activity of 
stem bark of Galipea longiflora Krause, a plant used by 
the Chimane Indians for the treatment of cutaneous 
leishmaniasis. The major quinoline alkaloid present in 
the stem bark and root bark, 2-phenylquinoline (I), did 
not show a high in vitro activity against extracellular 
forms of Leishinania ssp compared with the reference 
drug, Pentamidine. However, mice infected with 
Leishmania amazonensis (H-142) and treated with 2- 
phenylquinoline or Glucantime developed an equiva- 
lent lesion. This activity of 2-phenylquinoline was not 
as significant when mice were infected with the strain 
PH8 of Leislimariia aniazonensis. These results demon- 
strate the importance of infectivity of strains of 
Leishmania amazonensis which determine different 
drug responses (Trotter et al., 1980). The other quino- 
line alkaloid tested, 2-n-pentylquinoline did not show 
any effect when administered in infected BALB/c mice. 
In the literature quinolines are reported to have 
numerous biological activities (Farghaly et al. , 1990) 
molluscicidal (Vieira and Kubo, 1990) as well as anti- 
viral activities (Althaus et al., 1990), and therapeutic 
applications against malaria (Bryskier and Labro, 1988; 
Wommarck and Pearson, 1970) and Pneumocystis cari- 
nii (Queener et al., 1991). 
These ethnopharmacological, biological and chemi- 
cal studies showed that the poultices of stem bark of 
Galipea longiflora are most effective against cutaneous 
leishmaniasis. This work describes the first example of 
activity of 2-substituted quinoline against Leishmania 
species. 
Table 3. Effect of N-methylglucamine antimonate (56 mg of 
Sb' per kg per day), 2-phenylquinoline (I) (100 mg/ 
kg/day) and 2-n-pentylquinoline (II) (100 mg/kg/day) 
on the development of L. amazonensis PHS in 
BALB/c mice (-t SEM). Treatments were given for 
14 days period commencing 1 day after inoculation 
of L. amazonensis 
Diameter of lesiona 
Weeks post-infection Control Glucantime quinoline (I) quinoline (Il) 
2 0.53 (0.14) 0.17 (0.07) 0.67 (0.13) 0.32 (0.06) 
4 1.25 (0.16) 0.48 (0.15) 0.97 (0.15) 1.64 (0.15) 
6 3.80 (0.41) 2.35 (0.34) 3.52 (0.25) 3.77 (0.22) 
8 6.60 (0.43) 4.02 (0.41) 5.06 (0.37) 5.69 (0.35) 
a Average measurement (in mm) for 10 mice and +SEM. 
2-Phenyl 2-n-Pentyl 
Table 5. Effect of N-methylglucamine antimonate (112 mg of 
Sb' per kg per day), 2-phenylquinoline (I) (200 mg/ 
kg/day) on the development of L. amazonensis H-142 
in BALBlc mice (+SEM). Treatments were given on 
the infected rear footpad with a single treatment 14 
days after the inoculation of L. amazonensis 
Diameter of lesiona 
Weeks post-infection Control Glucantime 2-Phenylquinoline (1) 
2 0.35 (0.08) 0.45 (0.05) 0.47 (0.15) 
4 1.02 (0.20) 0.53 (0.23) 1.10 (0.18) 
6 2.87 (0.29) 1.52 (0.38) 2.62 (0.22) 
8 4.90 (0.42) 2.83 (0.58) 3.62 (0.52) 
a Average measurement (in mm) for 8 mice and &SEM. 
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The investigations on the antileishmanial activity of 
Galipea longiflora continue in our laboratory to deter- 
mine iTt vivo activities of the other quinoline alkaloids 
towards cutaneous leishmaniasis Of the New 
World (Leishmania “m?nsis  and L. UeneZUehsis) 
and the parasite of visceral leishmaniasis, L. donovani. 
Acknowledgements 
We express our sincere thanks to Padre Martin Bauer of the Mission 
Redentorista of Fatima (Department of Beni, Bolivia), to the 
Chimane Indians who gave essential logistic support and Dr J. A. 
Kallunki (New York Botanical Garden, NY, USA) for the identifica- 
tion of plant material. 
REFERENCES 
Althaus, I .  W., Reusser, F., Tarpley, W. G., and Skaletzky, L. L. 
(1990). PCT. lnt. Appl. WO 90, 05, 523. 
Avila, J. L., Rojas, T., Monzon, H., and Convit, J: (1990). 
Sinefungin as treatment for American Leishmania in sensi- 
tive BALB/c and resistant C57BU6 mice. Am. J. Trop. Med. 
Hyg. 43, 139-145. 
Bryskier, A., and Labro, M. T. (1988). Paludisme et Médicament, 
pp. 36-65. Editions Arnette, Paris. 
Coleman, R. E., Edman, J. D., and Semprevivo, L. H. (1989). The 
effect of pentostam and cimetidine on the development of 
leishmaniasis (Leishmania mexicana amazonensis) and 
concomitant malaria (Plasmodium yoelii). Ann. Trop. Med. 
Parasitol. 83, 339-344. 
Evans, D. A. (1987). Leishmania in vitro Methods for Parasite 
Cultivation, ed. by A. E. R. Taylor and J. R. Baker, pp. 52-75. 
Academic Press, New York. 
Farghaly, A. M., Habib, N. S., Khalil, M. A., and El-Sayed, O. A. 
(1990). Synthesis of novel 2-substituted quinoline deriva- 
tives: antimicrobial, inotropic, and chronotropic activities. 
Arch. Pharm. (Weinheim) 323, 247-251. 
Fournet, A. (1991). Plantes mèdicineles boliviennes antiparasit- 
aires (leishmaniose et maladie de Chagas): Galipea longif- 
lora (Rutaceae), Pera benensis (Euphorbiaceae) et 
Ampelocera edentula (Ulmaceae). Thesis (Pharmaceutical 
Sciences), University of Paris-Sud, France. 
Fournet, A., Angelo Barrios, A., Muñoz, V., Hocquemiller, R., 
Roblot, F., Bruneton, J., and Richomme, P. (1991). 
Quinoléines 2-substituées pour le traitement des leishma- 
nioses. French Patent No 91 12174. 
Fournet, A., Vagneur, B., Richomme, P., and Brunenon, J. (1989). 
Aryl-2 et alkyl-2 quinoléines nouvelles isolées d‘une Rutacée 
bolivienne: Galipea longiflora. Can. J. Chem. 67,2116-21 18. 
Martinez, S., Looker, D. L., and Marr, J. J. (1988). A tissue culture 
system for the growth of several species of Leishmania: 
growth kinetics and drug sensitivities. Am. J. Med. Hyg. 38, 
304-307. 
Neal, R. A., and Croft, S. L. (1984). An in vitro system for 
determining the activity of compounds against the intracel- 
lular amastigote forms of Leishmania donovani. J. 
Antimicrob. Chemother. 14, 463-475. 
Queener, S. F., Fujoka, H., Nishiyama, Y., Furukawa, H., Biartlett, 
M. S., and Smith, J. W. (1991). In vitro activities of acridone 
alkaloids against Pneumocystis carini;. Antimicrob. Agents 
Chemother. 35,377-379. 
Samuelson, J., Lerner, E., Tesh, R., and Titus, R. (1991). A mouse 
model of Leishmania braziliensis braziliensis infection pro- 
duced by coinjection with sand fly saliva. J. Exp. Med. 173, 
49-54. 
Trotter, E. R., Peters, W., and Robinson, B. L. (1980). The 
experimental chemotherapy of leishmaniasis, VI. The deve- 
lopment of rodent models for cutaneous infection with L. 
major and L. mexicana amazonensis. Ann. Trop. Med. 
Parasitol. 74, 299-31 9. 
Vieira, P. C., and Kubo, I. (1990). Molluscicidal quinoline alka- 
loids from Galipea bracteata. Phytochemistry 29, 813-815. 
Wommarck Jr, J. B., and Pearson, D. E. (1970). Potential antima- 
larials. IV. Quinoline-a, a dialkylmethanols. J. Med. Chem. 
13, 383-386. 
